A single-center, randomized, double-blind, crossover study to evaluate the abuse potential, pharmacokinetics,and safety of oral milled and intact extended-release hydrocodone (HYD) tablets in recreational opioid users

Trial Profile

A single-center, randomized, double-blind, crossover study to evaluate the abuse potential, pharmacokinetics,and safety of oral milled and intact extended-release hydrocodone (HYD) tablets in recreational opioid users

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2014

At a glance

  • Drugs Hydrocodone (Primary)
  • Indications Pain
  • Focus Pharmacodynamics
  • Sponsors Purdue Pharma
  • Most Recent Events

    • 06 May 2014 New trial record
    • 30 Apr 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top